Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Tags » Immu

Related tags: aria, arql, ctic, dna, dndn, hgsi, imgn, kerx, miti, sgen

  1. Immunomedics (IMMU) Reports Q2 EPS of $0.01

    streetinsider.com » StreetInsider.com News Articles - Feb 2, 2010

    Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Immunomedics+%28IMMU%29+Reports+Q2+EPS+of+%240.01/5297636.html for the full story.

  2. Trial Results Bode Well for Human Genome Sciences

    seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Nov 2, 2009

    EP Vantage submits: The high hopes that both the market and sufferers from lupus hold for Human Genome Sciences' (HGSI) lead drug, Benlysta, showed no signs of being dashed Monday after the group and partner

    Also tagged: gsk, hgsi, ep vantage

  3. Weekly Street Sentiment: Market Prepares for ‘Trick or Treat’

    seekingalpha.com » US Market Commentary from Seeking Alpha - Oct 27, 2009

    First Coverage submits: click to enlarge Sell-side comes dressed as unimpressed for Halloween With Halloween less than a week away, it seems quite appropriate that this market is ready to play with the fears, worries

    Also tagged: std, coh, wfc, lxk, gild, mtg, mco, bkh, wms, first coverage

  4. Mannkind Falls on Talk of Partner, FDA Delay: BioBuzz

    thestreet.com » TheStreet.com - Oct 6, 2009

    Company is delaying partnership talks for inhaled insulin product.

    Also tagged: drugs, biotech, health care, sqnm, acad, hgsi, mnkd, equities

  5. Immunomedics Gets a Lot of Things Right

    seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Oct 3, 2009

    EP Vantage submits: Immunomedics (IMMU) has had an outstanding year. The small New-Jersey based company has produced some of the biggest growth in the microcap sector and has seen its shares more than double since

    Also tagged: hgsi, rhhby pk, ep vantage

  6. Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

    seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Sep 20, 2009

    On Friday, Spectrum Pharmaceuticals (SPPI) announced the company sold $50 million worth of common shares at $7.55. As is often the case when a company sells additional shares, the share price fell. Shares of SPPI

    Also tagged: ctic, alth, miti, onxx, osip, gern, agn, scln, osir, aria, sgen, dndn, bcrx, slxp, exel, zgen, lgnd, gtxi, snta, regn, pard, hgsi, sppi, ogxi, dyax, supg, pgnx, incy, kerx, cytk, arql, imgn, mdvn, rigl, onty, idra, justin m hall

  7. Biotech Busy with Bevy of Small Deals

    seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Sep 12, 2009

    The Burrill Report submits: The global economy seems to be on the road to recovery, although it is a jobless recovery so far, according to economic indicators. Although there were no major deals during the past week

    Also tagged: abt, tgen, frx, orex, amln, fact, itmn, biib, genz, hnab, mipi, mbrx, rprx, kerx, cadx, the burrill report

  8. Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

    seekingalpha.com » Healthcare Sector and Stocks Analysis from Seeking Alpha - Sep 12, 2009

    As many, who have followed and/or invested in Spectrum Pharmaceuticals (SPPI), know Zevalin® was finally (and thankfully) approved last Friday, September 4, by the FDA for first-line consolidation use in patients with

    Also tagged: pfe, ctic, azn, nvs, gsk, alth, miti, onxx, osip, lly, bmy, gern, scln, osir, aria, sgen, biib, dndn, bcrx, slxp, exel, zgen, lgnd, gtxi, snta, regn, pard, hgsi, sppi, ogxi, dyax, supg, pgnx, incy, kerx, arql, bdsi, imgn, mdvn, byerf pk, rodm, onty, idra, justin m hall

  9. IMMU Announces Positive Lupus Drug Results

    seekingalpha.com » Biotech Sector and Stocks Analysis from Seeking Alpha - Sep 2, 2009

    Douglas Cress submits: Immunomedics (IMMU) has become the second biopharmaceutical company in recent weeks to announce a successful trial of its lupus drug. The company’s lupus medication, epratuzumab, showed a 24.9%

    Also tagged: gsk, hgsi, douglas cress

  10. After-Hours Movers 8/31: BEXP, HSP, MOT Higher; SINA, HCN, ARRY, IMMU Lower

    streetinsider.com » StreetInsider.com News Articles - Aug 31, 2009

    Brigham Exploration Company (NASDAQ: BEXP) 7% HIGHER; announced that the Figaro 29-32 #1H produced approximately 1,895 barrels of oil equivalent per day from the Bakken formation during its early peak 24 hour flow back

    Also tagged: mot, sina, bexp, hsp, arry, hcn

1  2  3  4  5